RISPERIDONE DIN 02571994
Health Canada record
| Active ingredient(s) | RISPERIDONE (RISPERIDONE TARTRATE) 1 MG |
|---|---|
| Dosage form | Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | N05AX08 RISPERIDONE |
| Original market date | |
| Current status date | 28-Sep-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sivem Pharmaceuticals ULC — licence 101965, currently licensed, last inspection rating C (2025-02-04).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing RISPERIDONE (RISPERIDONE TARTRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02279266 | PMS-RISPERIDONE | PHARMASCIENCE INC | Solution | RISPERIDONE (RISPERIDONE TARTRATE) 1 MG | Marketed |
| 02280396 | APO-RISPERIDONE | APOTEX INC | Solution | RISPERIDONE (RISPERIDONE TARTRATE) 1 MG | Dormant |
| 02364344 | AVA-RISPERIDONE | AVANSTRA INC | Solution | RISPERIDONE (RISPERIDONE TARTRATE) 1 MG | Cancelled Post Market |
| 02309572 | DOM-RISPERIDONE | DOMINION PHARMACAL | Solution | RISPERIDONE (RISPERIDONE TARTRATE) 1 MG | Cancelled Pre Market |
| 02454319 | JAMP RISPERIDONE | JAMP PHARMA CORPORATION | Solution | RISPERIDONE (RISPERIDONE TARTRATE) 1 MG | Dormant |
| 02236950 | RISPERDAL ORAL SOLUTION | JANSSEN INC | Solution | RISPERIDONE (RISPERIDONE TARTRATE) 1 MG | Cancelled Post Market |